Community lists
Sélection · Santé

Big pharma

Par InspectStocksPublished 14 oct. 202613 companies0 follower

The largest drugmakers, selling prescription medicines worldwide.

Regroupées avec l’aide d’un modèle d’IA et relues par notre rédaction. La ligne sous chaque entreprise indique pourquoi elle figure ici.

A
  • LLYELI Lilly
    1 437,79 $US+42,2 % 1Y

    Sells prescription medicines for diabetes, obesity, cancer and inflammation

  • JNJJohnson & Johnson
    280,34 $US+47,5 % 1Y

    Sells prescription medicines for cancer and immune disorders

  • MRKMerck
    147,20 $US+65,7 % 1Y

    Sells prescription medicines and vaccines for people and animals

  • NVSNovartis
    160,36 $US+23,6 % 1Y

    Sells prescription medicines

  • AMGNAmgen
    468,13 $US+43,1 % 1Y

    Develops and sells medicines and biosimilars for serious diseases

  • GSKGSK
    50,60 $US+8,9 % 1Y

    Sells prescription medicines and vaccines worldwide

  • TAKTakeda Pharmaceutical
    20,86 $US+50,1 % 1Y

    Sells prescription medicines and vaccines globally

B
  • ABBVAbbVie
    294,87 $US+30,2 % 1Y

    Sells medicines for immune, neurological and cancer conditions

  • AZNUn cran plus bas parce que la croissance s’essouffleAstrazeneca
    185,49 $US+115,2 % 1Y

    Sells prescription medicines

  • SNYSanofi
    48,43 $US-3,0 % 1Y

    Sells prescription medicines and vaccines

C
  • NVONovo Nordisk A/S
    41,10 $US-15,4 % 1Y

    Sells diabetes and obesity medicines

  • PFEUn cran plus bas parce que la croissance s’essoufflePfizer
    29,45 $US+21,4 % 1Y

    Sells prescription medicines and vaccines

  • BMYBristol-Myers Squibb
    62,92 $US+34,0 % 1Y

    Sells prescription medicines for cancer and immune conditions

D

Aucune entreprise ici n’a cette note.

F

Aucune entreprise ici n’a cette note.

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.